|
CN1219878A
(zh)
*
|
1996-03-25 |
1999-06-16 |
伊莱利利公司 |
治疗疼痛的方法
|
|
EP0906104A4
(en)
|
1996-03-25 |
2003-12-10 |
Lilly Co Eli |
PAIN TREATMENT PROCESS
|
|
CA2250155A1
(en)
*
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Anesthetic method
|
|
ZA977967B
(en)
*
|
1996-09-23 |
1999-03-04 |
Lilly Co Eli |
Combination therapy for treatment of psychoses
|
|
US20040208926A1
(en)
*
|
1997-07-01 |
2004-10-21 |
Pfizer Inc |
Solubilized sertraline compositions
|
|
NZ513456A
(en)
|
1997-07-01 |
2003-02-28 |
Pfizer |
Sertraline acetate, L-lactate and L-aspartate, processes for their preparation and their uses in psychotic disorders
|
|
US20030133974A1
(en)
*
|
1997-07-01 |
2003-07-17 |
Curatolo William John |
Encapsulated solution dosage forms of sertraline
|
|
WO1999061027A1
(en)
*
|
1998-05-22 |
1999-12-02 |
Eli Lilly And Company |
Combination therapy for treatment of refractory depression
|
|
US6960577B2
(en)
|
1998-05-22 |
2005-11-01 |
Eli Lilly And Company |
Combination therapy for treatment of refractory depression
|
|
AU756468B2
(en)
*
|
1998-05-29 |
2003-01-16 |
Eli Lilly And Company |
Combination therapy for treatment of bipolar disorders
|
|
WO2000015223A1
(en)
*
|
1998-09-15 |
2000-03-23 |
Eli Lilly And Company |
Treatment of persistent pain
|
|
EP2090312A1
(en)
|
1999-07-01 |
2009-08-19 |
Pharmacia & Upjohn Company LLC |
(S,S) reboxetine for treating attention deficit disorder
|
|
AU2001280699A1
(en)
*
|
2000-07-21 |
2002-02-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
|
|
ATE301995T1
(de)
*
|
2000-08-17 |
2005-09-15 |
Teva Pharma |
Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
|
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
|
MXPA04007752A
(es)
*
|
2002-02-08 |
2005-06-17 |
Abbott Lab |
Terapia de combinacion para tratamiento de esquizofrenia.
|
|
JP2005522445A
(ja)
*
|
2002-02-12 |
2005-07-28 |
サイプレス バイオサイエンス， インコーポレイテッド |
注意欠陥過活動性障害（ａｄ／ｈｄ）の処置方法
|
|
CN1662231A
(zh)
*
|
2002-04-24 |
2005-08-31 |
柏树生物科学公司 |
包括应激相关障碍在内的功能性躯体障碍的预防与治疗
|
|
US6881829B2
(en)
*
|
2002-04-26 |
2005-04-19 |
Chimeracom, L.L.C. |
Chimeric hybrid analgesics
|
|
WO2003101492A2
(en)
*
|
2002-05-30 |
2003-12-11 |
Neurosearch A/S |
Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain
|
|
US20040106681A1
(en)
*
|
2002-10-03 |
2004-06-03 |
Cypress Bioscience, Inc. |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
|
CN1717237A
(zh)
|
2002-11-26 |
2006-01-04 |
艾利斯达分子传输公司 |
洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
|
|
MXPA05005609A
(es)
*
|
2002-11-26 |
2005-07-26 |
Alexza Pharmaceuticals Inc |
Tratamiento de dolor de cabeza con antipsicoticos suministrados por inhalacion.
|
|
AR042806A1
(es)
*
|
2002-12-27 |
2005-07-06 |
Otsuka Pharma Co Ltd |
Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
|
|
EP1723957A3
(en)
|
2002-12-27 |
2013-01-23 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
|
|
WO2004105690A2
(en)
*
|
2003-05-23 |
2004-12-09 |
Cypress Bioscience, Inc. |
Treatment of chronic pain associated with drug or radiation therapy
|
|
US7419980B2
(en)
|
2003-10-14 |
2008-09-02 |
Wyeth |
Fused-aryl and heteroaryl derivatives and methods of their use
|
|
US7365076B2
(en)
|
2003-10-14 |
2008-04-29 |
Wyeth |
Substituted aryl cycloalkanol derivatives and methods of their use
|
|
US7531543B2
(en)
|
2003-10-14 |
2009-05-12 |
Wyeth |
Phenylpiperazine cycloalkanol derivatives and methods of their use
|
|
US7491723B2
(en)
|
2003-10-14 |
2009-02-17 |
Wyeth |
Alkanol and cycloalkanol-amine derivatives and methods of their use
|
|
US7402698B2
(en)
|
2003-10-14 |
2008-07-22 |
Wyeth |
Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
|
|
US7550485B2
(en)
|
2003-10-14 |
2009-06-23 |
Wyeth |
Substituted N-heterocycle derivatives and methods of their use
|
|
US7524846B2
(en)
|
2003-10-14 |
2009-04-28 |
Wyeth |
Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
|
|
DE102004011392A1
(de)
*
|
2004-01-13 |
2005-08-04 |
Grünenthal GmbH |
Schwache bis mittelstarke Opioide oder Kombinationen dieser Opioide mit Antidepressiva für die Behandlung von Depressionen, Angststörungen und Schmerzen
|
|
US7517899B2
(en)
|
2004-03-30 |
2009-04-14 |
Wyeth |
Phenylaminopropanol derivatives and methods of their use
|
|
US7414052B2
(en)
|
2004-03-30 |
2008-08-19 |
Wyeth |
Phenylaminopropanol derivatives and methods of their use
|
|
TWI432196B
(zh)
*
|
2005-01-18 |
2014-04-01 |
Euro Celtique Sa |
內臟痛的治療
|
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
WO2007062119A1
(en)
*
|
2005-11-23 |
2007-05-31 |
Auspex Pharmaceuticals, Inc. |
Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
|
|
WO2007067714A2
(en)
*
|
2005-12-08 |
2007-06-14 |
The Mclean Hospital Corporation |
Treatment of sequelae of psychiatric disorders
|
|
WO2007096489A1
(fr)
*
|
2006-02-17 |
2007-08-30 |
Trimaran Limited |
Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions
|
|
US8536445B2
(en)
*
|
2006-06-02 |
2013-09-17 |
Emcore Solar Power, Inc. |
Inverted metamorphic multijunction solar cells
|
|
US20080102097A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Zanella John M |
Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
|
|
US20080031950A1
(en)
*
|
2007-04-27 |
2008-02-07 |
Nectid Inc. |
Novel anelgesic combination
|
|
US20080026054A1
(en)
*
|
2007-04-27 |
2008-01-31 |
Nectid Inc. |
Novel anelgesic combination
|
|
US8470360B2
(en)
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
|
US8138169B2
(en)
|
2008-04-11 |
2012-03-20 |
Comgenrx, Inc. |
Combination therapy for bipolar disorder
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US8946277B2
(en)
*
|
2008-04-18 |
2015-02-03 |
Warsaw Orthopedic, Inc. |
Clonidine formulations in a biodegradable polymer carrier
|
|
US9132085B2
(en)
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US9072727B2
(en)
*
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
|
US8722079B2
(en)
*
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US20090263451A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
|
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US9610243B2
(en)
|
2008-04-18 |
2017-04-04 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US8629172B2
(en)
*
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
|
US8956641B2
(en)
*
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
|
US20090263489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
|
|
US8557273B2
(en)
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
|
US8822546B2
(en)
*
|
2008-12-01 |
2014-09-02 |
Medtronic, Inc. |
Flowable pharmaceutical depot
|
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
|
US8617583B2
(en)
*
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
|
US8231891B2
(en)
*
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
|
HRP20240285T1
(hr)
|
2011-03-18 |
2024-05-24 |
Alkermes Pharma Ireland Limited |
Farmaceutski pripravci koji sadrže sorbitan estere
|
|
GB2491118B
(en)
|
2011-05-20 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
EP2827866B1
(en)
|
2012-03-19 |
2023-05-03 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising benzyl alcohol
|
|
ES2764383T3
(es)
|
2012-03-19 |
2020-06-03 |
Alkermes Pharma Ireland Ltd |
Composiciones farmacéuticas que comprenden ésteres de glicerol
|
|
AU2013235519C1
(en)
*
|
2012-03-19 |
2018-04-26 |
Alkermes Pharma Ireland Limited |
Pharmaaceutical compositions comprising fatty acid esters
|
|
ES2792149T3
(es)
|
2012-09-19 |
2020-11-10 |
Alkermes Pharma Ireland Ltd |
Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada
|
|
SMT202200094T1
(it)
|
2013-12-24 |
2022-05-12 |
Univ Virginia Commonwealth |
Uso di solfati di colesterolo ossigenati (ocs) per il trattamento dell’insufficienza epatica acuta
|
|
MX376057B
(es)
|
2014-03-20 |
2025-03-07 |
Alkermes Pharma Ireland Ltd |
Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion.
|
|
EP3468540A4
(en)
*
|
2016-06-13 |
2020-03-18 |
Board Of Regents Of the University Of Texas System |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING PAIN
|
|
AU2019230014B2
(en)
|
2018-03-05 |
2024-11-28 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
|
WO2020093098A1
(en)
*
|
2018-11-07 |
2020-05-14 |
The University Of Melbourne |
Novel compounds for the treatment of respiratory diseases
|